Swainsonine

Overview
Swainsonine is a potent inhibitor of Golgi alpha-mannosidase II, immunomodulator and potential anticancer agent. Disruption of Golgi alpha-mannosidase II with swainsonine induces hybrid-type glycans. These glycans have a Man5GlcNAc2 core with processing on the 3-arm that resembles so-called complex-type glycans.

The pharmacological properties of this product have not been fully investigated.

Handling Instructions

 * Soluble in water (10 mg/1 ml) and ethanol
 * Use caution when handling.
 * This product must not be used in humans
 * Store between 0-4 ˚C for up to 1 year
 * Store or 20 ˚C for up to 3 months
 * Disposal: A